Biología molecular del cáncer
Rochester General Hospital
Rochester, Estados UnidosPublications en collaboration avec des chercheurs de Rochester General Hospital (1)
2022
-
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Critical Care, Vol. 26, Núm. 1